RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
RISK-ADAPT Protocol in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)	Metastatic Hormone-sensitive Prostate Cancer (mHSPC)	Not yet recruiting	Phase 2	2026-10-06		NCT07645326

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Georgetown University	73
Lantheus Medical Imaging	15

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Georgetown University Medical Center- Lombardi Comprehensive Cancer Center	Washington D.C.	United States	1

Clinical trials